Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)

Clinical trial NCT06825091 · RECRUITING

Trial details

NCT number: NCT06825091
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Localized Prostate Cancer Stereotactic Body Radiotherapy

Start date: 2025-02-04
Primary completion: 2030-02-04
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.